Faculty, Staff and Student Publications

Language

English

Publication Date

9-12-2025

Journal

Aging

DOI

10.18632/aging.206319

PMID

40952372

PMCID

PMC12705187

PubMedCentral® Posted Date

9-12-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease characterized by the accumulation of misfolded proteins in the brain. Recently, the impact of blood components in the progression of this disease has come to attention. This study investigates the effects of infusing blood from young and old wild-type mice into transgenic mice that model AD brain amyloidosis. Impaired memory and Aβ accumulation were observed in mice infused with blood from old donors. A proteomic analysis in the brain of these mice identified alterations in components related to synaptogenesis and the endocannabinoid system. The α2δ2 protein, associated with neuronal calcium regulation, was validated as a possible mediator of the observed effects. This study highlights the influence of blood in AD pathology and the identification of potential therapeutic targets.

Keywords

Animals, Alzheimer Disease, Mice, Transgenic, Mice, Amyloid beta-Peptides, Brain, Disease Models, Animal, Aging, Amyloidosis, Proteomics, Alzheimer’s disease, amyloid-β, neurodegeneration, protein misfolding, blood infusion, therapeutic targets

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.